DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development
Launched by UNIVERSITY OF FLORIDA · May 3, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The DEUX OEUFs trial is studying whether eating two eggs a day during pregnancy can help babies grow longer at birth. Researchers believe that mothers who eat this way will have babies that are taller than those whose mothers eat a typical diet. The trial involves 956 pregnant women from the Nyagatare District in Rwanda. Participants will be divided into two groups: one group will receive two eggs each day, while the other group will continue with their usual diet. Both groups will receive important health information and care during their pregnancy.
To participate in this study, women need to be between 18 and 44 years old, live in the study area, and be in the early stages of pregnancy (9-14 weeks) confirmed by an ultrasound. Throughout the study, participants will undergo regular check-ups, including ultrasounds and blood tests, to monitor their health and the growth of their babies. Additionally, all mothers will receive support, such as a mobile phone and health insurance, to help them stay engaged in the study. This trial aims to gather valuable information about how maternal nutrition, specifically egg consumption, might influence child growth and development.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Lives in study area (catchment area of Karangazi Health Center and Ndama Health Center)
- • Confirmed viable intrauterine pregnancy (confirmed via ultrasound)
- • Aged between 18-44 years
- • 9-14 weeks gestation (confirmed via ultrasound, up to 13 weeks +6 days)
- • Agrees to participate with informed consent
- Exclusion Criteria:
- • Intention to move outside the study area in next 12 months
- • Intention to deliver at a location outside of Eastern Province Nyagatare District
- • Any known adverse reaction to eating eggs or porridge ingredients
- • Any condition that could affect the ability to comply with the study requirements or understand the informed consent process
- • Participation in other clinical trials (to avoid burden and potential interactions between interventions)
- • Any individual unable or unwilling to comply with the study requirements, such as attending regular follow-up visits or adhering to prescribed nutritional supplementation.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nyagatare, , Rwanda
Patients applied
Trial Officials
Sarah McKune, PhD, MPH
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported